These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3037887)

  • 1. Angiotensin-converting enzyme inhibitors: considerations regarding proteinuria.
    Lewis EJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):30-8. PubMed ID: 3037887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of captopril-induced renal insufficiency after prolonged use in an unusual case of renovascular hypertension.
    Salahudeen AK; Pingle A
    J Hum Hypertens; 1988 Jun; 2(1):57-9. PubMed ID: 3070035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and stenosis of the graft artery: effects of conversion enzyme inhibition].
    Mourad G; Ribstein J; Argiles A; Mion C; Mimran A
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):892-5. PubMed ID: 3099707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin-converting enzyme inhibition: side effects and risks].
    Schilling H; Scheler F
    Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M; Delin K; Herlitz H
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril-associated granulocytopenia in hypertension after renal transplantation.
    Shindo K; Matsuya F; Ura T; Jodai A; Shimomae H; Kuniyoshi M; Hirose T; Kusaba Y; Saito Y
    Clin Nephrol; 1984 Dec; 22(6):314-6. PubMed ID: 6396008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
    Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition in hypertension.
    Robertson JI; Tillman DM; Ball SG; Lever AF
    J Hypertens Suppl; 1987 Aug; 5(3):S19-25. PubMed ID: 3312525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictability of post-captopril acute renal failure in hypertension with renal artery stenosis of a single kidney or bilateral stenosis].
    Durand D; Ader JL; Lloveras JJ; Tran Van T; Chamoiseau S; Suc JM
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):888-91. PubMed ID: 3099706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis.
    van der Woude FJ; van Son WJ; Tegzess AM; Donker AJ; Slooff MJ; van der Slikke LB; Hoorntje SJ
    Nephron; 1985; 39(3):184-8. PubMed ID: 2983251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.